GlassScriptPhysician profile
Panagiotis Panagakos
NPI 1629211263
$6,622.23
in general payments reported to CMS, 2019-2025
33 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $329 · 2021: $1,210 · 2022: $1,657 · 2023: $892 · 2024: $1,234 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,565.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,245.06 | 2019-2025 | Inbone, Variax, Augment Injectable |
| Treace Medical Concepts, INC. | $1,007.32 | 2021-2025 | |
| Organogenesis INC. | $446.71 | 2019-2025 | Apligraf |
| Smith+Nephew, INC. | $381.49 | 2021-2025 | Grafix Pl, Stravix Pl, Oasis |
| Ossio INC | $243.20 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $219.74 | 2021-2025 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $177.60 | 2020-2021 | |
| Orthofix Medical, INC. | $130.89 | 2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $111.91 | 2021 | |
| Nevro Corp. | $64.36 | 2021-2024 | Senza |
| Convatec INC. | $51.51 | 2019-2023 | |
| Integra Lifesciences Corporation | $48.35 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acumed LLC | $46.12 | 2022 | |
| Boston Scientific Corporation | $42.17 | 2019-2023 | |
| Stimwave Technologies Incorporated | $40.55 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $38.65 | 2022 | |
| Bioventus LLC | $37.35 | 2019-2021 | |
| Wright Medical Technology, INC. | $29.12 | 2019 | |
| Horizon Therapeutics Plc | $26.81 | 2022 | |
| Sebela Pharmaceuticals INC. | $25.82 | 2022-2023 | Naftin |
| Abbott Laboratories | $24.22 | 2023 | Proclaim |
| Si-Bone, INC. | $23.44 | 2021 | |
| Kerecis Limited | $23.20 | 2020 | |
| Medtronic, INC. | $17.13 | 2024 | Intellis Adaptivestim |
| Averitas Pharma INC. | $16.51 | 2024 | Qutenza |
| Alexion Pharmaceuticals, INC. | $14.89 | 2020 | |
| Grt US Holding, INC. | $14.09 | 2022 | |
| Dynasplint Systems INC. | $14.01 | 2025 | Dynasplint |
| Paragon 28, INC. | $13.89 | 2021 | |
| Melinta Therapeutics, LLC | $12.61 | 2019 | |
| Alfasigma USA, INC. | $11.65 | 2021 | |
| Sandoz INC. | $11.01 | 2019 | |
| Axogen | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Panagiotis Panagakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.